Online citations, reference lists, and bibliographies.
← Back to Search

Dose-volume Histogram Analysis As Predictor Of Radiation Pneumonitis In Primary Lung Cancer Patients Treated With Radiotherapy.

M. Fay, A. Tan, R. Fisher, M. M. Mac Manus, A. Wirth, D. Ball
Published 2005 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
PURPOSE To determine the relationship between various parameters derived from lung dose-volume histogram analysis and the risk of symptomatic radiation pneumonitis (RP) in patients undergoing radical radiotherapy for primary lung cancer. METHODS AND MATERIALS The records of 156 patients with lung cancer who had been treated with radical radiotherapy (>/=45 Gy) and for whom dose-volume histogram data were available were reviewed. The incidence of symptomatic RP was correlated with a variety of parameters derived from the dose-volume histogram data, including the volume of lung receiving 10 Gy (V(10)) through 50 Gy (V(50)) and the mean lung dose (MLD). RESULTS The rate of RP at 6 months was 15% (95% confidence interval 9-22%). On univariate analysis, only V(30) (p = 0.036) and MLD (p = 0.043) were statistically significantly related to RP. V(30) correlated highly positively with MLD (r = 0.96, p < 0.001). CONCLUSION V(30) and MLD can be used to predict the risk of RP in lung cancer patients undergoing radical radiotherapy.
This paper references



This paper is referenced by
10.1016/J.IJROBP.2006.03.063
Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
Eng-Siew Koh (2006)
10.3109/0284186X.2010.521192
Heart irradiation as a risk factor for radiation pneumonitis
E. Huang (2011)
10.4172/2155-9619.1000149
Predictive Factors for Radiation Pneumonitis in Patients Receiving Intensity-modulated Radiation Therapy for Thoracic Malignancy
E AleksSorra (2013)
10.1016/J.IJROBP.2006.09.030
Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates.
J. Schallenkamp (2007)
10.1080/10420150.2012.669764
A study on quantitative analysis of field size and dose by using gating system in 4D conformal radiation treatment
Youn-Sang Ji (2012)
10.1007/174_2011_283
Intensity-Modulated Radiation Therapy and Volumetric-Modulated Arc Therapy for Lung Cancer
Inga Siiner Grills (2011)
10.1016/B978-0-323-24098-7.00014-9
Chapter 14 – Late Effects after Radiation
Michael T Milano (2016)
adiotherapy in Lung CanCer
S. Vinod (2013)
Risk factors for radiation pneumonitis after radiotherapy in lung cancer patients : a systematic review and meta-analysis
D. Liu (2016)
10.1002/cam4.3446
Simultaneous integrated boost of intensity‐modulated radiation therapy to Stage II‐III non‐small cell lung cancer with metastatic lymph nodes
Q. Li (2020)
10.1016/j.ijrobp.2017.04.011
Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy.
R. Wijsman (2017)
10.1016/J.IJROBP.2005.11.046
Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters.
A. Hope (2006)
10.1016/B978-1-4377-1637-5.00075-4
Chapter 75 – Non-Hodgkin's Lymphoma
R. W. Tsang (2012)
10.1016/j.radonc.2015.09.001
Radiation-induced lung damage - Clinical risk profiles and predictive imaging on their way to risk-adapted individualized treatment planning?
N. Ebert (2015)
10.1016/j.radonc.2008.12.002
The importance of patient characteristics for the prediction of radiation-induced lung toxicity.
C. Dehing-Oberije (2009)
10.1038/s41598-020-68168-y
Relationship between radiation doses to heart substructures and radiation pneumonitis in patients with thymic epithelial tumors
N. Tomita (2020)
10.7150/jca.12314
Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer
Shuiyun Han (2015)
10.1016/j.semradonc.2012.11.002
Biological considerations when comparing proton therapy with photon therapy.
H. Paganetti (2013)
10.1007/s00066-019-01552-4
Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters
Y. Zhou (2019)
10.1016/B978-1-4377-1637-5.00013-4
Chapter 13 – Survivorship and Late Effects
M. Milano (2011)
10.1088/0031-9155/53/3/014
Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
V. Semenenko (2008)
10.1038/srep23543
Dosimetric evaluation of a simple planning method for improving intensity-modulated radiotherapy for stage III lung cancer
J. Lu (2016)
10.1186/s13014-016-0580-3
Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy – a single-centre experience
C. Henkenberens (2016)
10.3857/JKSTRO.2009.27.4.240
A Dose Volume Histogram Analyzer Program for External Beam Radiotherapy
J. Kim (2009)
10.1016/j.ijrobp.2009.05.055
Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer.
S. Tucker (2010)
10.1016/j.radonc.2012.04.003
[18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients.
M. McCurdy (2012)
10.1093/jjco/hyn158
Prediction of radiation pneumonitis following high-dose thoracic radiation therapy by 3 Gy/fraction for non-small cell lung cancer: analysis of clinical and dosimetric factors.
D. Oh (2009)
10.1097/JTO.0b013e3181653ca6
Association between Systemic Chemotherapy before Chemoradiation and Increased Risk of Treatment-Related Pneumonitis in Esophageal Cancer Patients Treated with Definitive Chemoradiotherapy
S. Wang (2008)
10.1016/j.ctro.2020.02.004
Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer
K. A. Al Feghali (2020)
10.3389/fimmu.2017.00506
Immunological Aspect of Radiation-Induced Pneumonitis, Current Treatment Strategies, and Future Prospects
A. Kainthola (2017)
10.1016/j.ijrobp.2009.09.030
Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
R. Bryan Barriger (2010)
10.1016/j.ijrobp.2009.08.021
Lung dose for minimally moving thoracic lesions treated with respiration gating.
I. Mihaylov (2010)
See more
Semantic Scholar Logo Some data provided by SemanticScholar